about
sameAs
Perlecan domain IV peptide stimulates salivary gland cell assembly in vitroA central function for perlecan in skeletal muscle and cardiovascular developmentPerlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis.A current view of perlecan in physiology and pathology: A mosaic of functions.Identification of novel chondroitin proteoglycans in Caenorhabditis elegans: embryonic cell division depends on CPG-1 and CPG-2Perlecan, a candidate gene for the CAPB locus, regulates prostate cancer cell growth via the Sonic Hedgehog pathwayExpression, functional, and structural analysis of proteins critical for otoconia developmentThe proteoglycan Trol controls the architecture of the extracellular matrix and balances proliferation and differentiation of blood progenitors in the Drosophila lymph glandMechanisms of otoconia and otolith developmentProteomic profiling of endorepellin angiostatic activity on human endothelial cellsEndostatin and endorepellin: A common route of action for similar angiostatic cancer avengersDiverse cell signaling events modulated by perlecan.Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue bordersPerlecan immunolocalizes to perichondrial vessels and canals in human fetal cartilaginous primordia in early vascular and matrix remodeling events associated with diarthrodial joint development.The enhanced permeability retention effect: a new paradigm for drug targeting in infection.Integrin alpha2beta1 is the required receptor for endorepellin angiostatic activity.A novel peptide sequence in perlecan domain IV supports cell adhesion, spreading and FAK activation.Chondrogenic differentiation on perlecan domain I, collagen II, and bone morphogenetic protein-2-based matrices.Perlecan is required for the chondrogenic differentiation of synovial mesenchymal cells through regulation of Sox9 gene expression.
P2860
Q24642832-DECB7995-9070-41CB-8942-BF0242A8A9ECQ24648227-5756E22E-549B-490D-93EF-F45EB6349F9AQ24653433-7A26913D-E1C2-4904-BBEF-65E8BAB6D56EQ30392738-D4740C6C-604A-478D-962D-0B4D75043C62Q30480412-146915BF-0571-40E8-893B-991598AA06A2Q34499215-AE60A0EF-81B9-44F3-AD43-FBE0096898AAQ34724531-AB61700C-D333-46B0-894E-1AD25CC8E1DDQ34783479-3C117D73-FE7E-4A3F-8E86-45A1DE16280FQ35788255-B3F05B44-EC4E-4229-B0E1-0EFD046C28EDQ36509450-6C701E72-AFD5-4DC7-A2F9-5C2F528A901FQ36578668-C8331ABE-A6F2-4CFE-9D14-AD9FDF11B943Q37020797-BEE469E6-6B2C-4689-8B47-31CB9B704502Q37610826-ABADB4BC-4723-4C0E-9F99-0DE66264EAF8Q37643577-7832E749-7705-4FF2-B0FE-567407CA89ECQ38051263-BAECC318-EB8F-4A09-93B7-9066419FBC4CQ40048806-2123A00F-5BF3-4329-9CA4-1C61FFA15E97Q40053261-D4003F37-93FC-4F95-813C-981848FD876BQ40247376-4B9EA2DB-D0A1-42A7-B490-F9626A2DA8F3Q53604003-8BE8AD09-A44A-43E7-ABB6-92476622DD6D
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականին հրատարակուած գիտական յօդուած
@hyw
2002 թվականին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Role of perlecan in skeletal development and diseases
@ast
Role of perlecan in skeletal development and diseases
@en
Role of perlecan in skeletal development and diseases
@nl
type
label
Role of perlecan in skeletal development and diseases
@ast
Role of perlecan in skeletal development and diseases
@en
Role of perlecan in skeletal development and diseases
@nl
prefLabel
Role of perlecan in skeletal development and diseases
@ast
Role of perlecan in skeletal development and diseases
@en
Role of perlecan in skeletal development and diseases
@nl
P2093
P356
P1476
Role of perlecan in skeletal development and diseases
@en
P2093
Eri Arikawa-Hirasawa
John Hassell
Yoshihiko Yamada
P2888
P356
10.1023/A:1025340215261
P407
P577
2002-01-01T00:00:00Z
P6179
1012540365